Please login to the form below
AS
This page shows the latest AS news and features for those working in and with pharma, biotech and healthcare.
EU “still interested” in Valneva COVID vaccine despite UK snub
Negotiations between Valneva and the EU are “ongoing and advanced”, with its vaccine candidate VLA2001 touted as a potential booster shot in France. ... The EU is still interested in this vaccine,” said the source, suggesting that the Valneva
Latest news
-
Orphan status in Europe for lymphoma drug Zynlonta
We are committed to providing global access to Zynlonta for as many patients as may benefit.”. ... ZYNLONTA is also in late-stage clinical trials in combination with other agents and is being evaluated as a monotherapy.
-
UK announces COVID boosters for a “bumpy winter” ahead
The government is already offering booster shots to half a million people who are classed as clinically extremely vulnerable. ... The main aim of the booster programme is to prolong that protection and reduce serious disease as we head towards the colder
-
Valneva shares fall as UK cancels COVID-19 vaccine order
However, none of these scenarios are evident as an explanation for the sudden termination. ... This has come as a huge blow to my constituency.”. VLA2001 is currently the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials
-
Embattled Biogen talks up Aduhelm
He cited three near-term priorities for the company as it seeks to overcome the many hurdles in the way of its drug. ... pathway. With more than six million Americans living with Alzheimer’s disease, the price tag to the US healthcare system will be
-
Behaviour change theory
Hmmm. As an added boon for marketers, the op-ed proffered advice on how to ‘get patients or HCPs to do something different’. ... It’s not new, it’s just been given a label as a behaviour change technique.
Orphan status in Europe for lymphoma drug Zynlonta
UK announces COVID boosters for a “bumpy winter” ahead
Valneva shares fall as UK cancels COVID-19 vaccine order
Embattled Biogen talks up Aduhelm
Behaviour change theory
More from news
Approximately 2 fully matching, plus 7,549 partially matching documents found.
Latest Intelligence
-
Health For All
Working in healthcare doesn’t prevent this – a systematic review of 42 studies of implicit bias among healthcare professionals found doctors and nurses manifest biases to the same extent as the ... general public – in response to characteristics as
-
Taking centre stage: the role of behaviour change initiatives in the management of long-term conditions
Consequently, symptoms such as fatigue, depression and pain will increasingly be selected as trial endpoints. ... For example, specialist nurses could be trained in delivering behavioural support, or a software as a medical device (SaMD) solution could
-
To avoid making mistakes when applying behavioural insights in healthcare, we need to understand why people do what they do
but instead saw the teenage mother delivering the messages as independent, together and confident, with rights and financial support, and they wanted what she had. ... healthcare. We have limited populations of specialists, patients and other healthcare
-
Are healthcare brands finally wising up to the power of creative-led communications?
more than ever?” As you can imagine, with speakers representing ad agency and PR life as well the Cannes Lions team, the consensus on the day was a unanimous yes. ... Because healthcare innovation deserves a communications approach that is just as
-
Mastering oneself
As with learning self-mastery, failure to do so seems to be idiosyncratic and related to personality type. ... Whether that is achieved and how it is achieved is strongly influenced by personality characteristics such as the big five traits.
Health For All
Taking centre stage: the role of behaviour change initiatives in the management of long-term conditions
To avoid making mistakes when applying behavioural insights in healthcare, we need to understand why people do what they do
Are healthcare brands finally wising up to the power of creative-led communications?
Mastering oneself
More from intelligence
Approximately 0 fully matching, plus 1,344 partially matching documents found.
Latest appointments
-
David Hunt launches independent agency The Considered
During Hunt’s tenure as CEO of Havas Lynx, he grew the company from a small creative agency into a global healthcare comms outfit, with the agency receiving a number of
-
Ashfield Engage appoints Serap Becker as head of patient solutions in DACH region
Prior to joining Ashfield Engage, Becker served as director of direct to patient services at Marken. ... UDG Healthcare company Ashfield Engage has announced the appointment of Serap Becker (pictured above) as its new head of patient solutions in the
-
AZ appoints Susan Galbraith as executive vice president, oncology R&D
AstraZeneca (AZ) has announced the appointment of Susan Galbraith (pictured above) as executive vice president, oncology research and development (R&D). ... I am honoured to take on this position as we continue our work to one day cure cancer.
-
Hanover Health appoints Aleksandra Lugović as an associate director
Interruption in business-as-usual caused by the pandemic, offers an opportunity for a new beginning. ... We will focus on continuing to position Hanover as a front-runner among integrated strategic agencies in Brussels in the post-COVID era,” she added.
-
EFPIA appoints Hubertus von Baumbach as president
Von Baumbach will serve as president of the EFPIA for the next two years. ... Commenting on his appointment as president of the EFPIA, von Baumbach said: “The pandemic has severely tested European health and economic resilience.
David Hunt launches independent agency The Considered
Ashfield Engage appoints Serap Becker as head of patient solutions in DACH region
AZ appoints Susan Galbraith as executive vice president, oncology R&D
Hanover Health appoints Aleksandra Lugović as an associate director
EFPIA appoints Hubertus von Baumbach as president
More from appointments
Approximately 0 fully matching, plus 1,186 partially matching documents found.
Latest from PMHub
-
Nicky Hutchens appointed as deputy managing director at Four Health
Healthcare communications agency Four Health has announced the appointment of Nicky Hutchens (pictured above) as its new deputy managing director. ... Hutchens initially joined Four Health in 2017 as an account director, before progressing to practice
-
A Lucid Group Thirsty Thursday Special: Beautiful Rejects
No, it does not. As 18th century polymath Johann Wolfgang von Goethe famously reflected:. ... As Craig Bruce said:. “Nothing surpasses the beauty and elegance of a bad idea.”.
-
A day in the life of a PR Account Director
As a team, we often have to manage and deliver to tight, conflicting deadlines. ... 5) Do you have any advice for those considering a career as an Account Director.
-
Health literacy in the time of COVID-19
However, it has also further polarized the population when it comes to public health measures such as vaccines and face masks. ... The most important determinants of COVID-19 vaccine hesitancy were distrust of the vaccine safety and general vaccine
-
Maximize your training investments with learning and development specialists
the credibility of your medical affairs team as a key partner in the healthcare industry. ... development process, as well as how they can work with you to communicate best with your learners.
Nicky Hutchens appointed as deputy managing director at Four Health
More from PMHub
Approximately 2 fully matching, plus 1,062 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Embattled Biogen talks up Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- bluebird bio gears up for split
- EU identifies first five ‘promising’ COVID-19 drugs as part of therapeutics strategy
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Nicky Hutchens appointed as deputy managing director at Four Health
- Health For All
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
- Accelerating Drug Development Timelines with Big Data Analytics
- A Lucid Group Thirsty Thursday Special: Beautiful Rejects
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- EU “still interested” in Valneva COVID vaccine despite UK snub
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Lilly to target difficult-to-treat disease through tie-up with Lycia
- Sanofi/Regeneron bag first approval for Actemra rival sarilumab
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
